한국지질동맥경화학회 학술대회

Epidemiologic evidence on Lp(a) and ASCVD in Asian populations

The inverse link between Lp(a) and metabolic risk: signal or noise?

Lp(a) testing today: mind the method, mind the unit

CVD risk prediction in low-risk population

CVD risk prediction in older persons

CVD risk prediction in diabetes and high-risk patients

LDL-C targets for patients with diabetes across major guidelines

Pro: all patients with diabetes should be treated to LDL-C <55 mg/dL?

Cons: LDL-C targets should be personalized in diabetic patients?

Upfront lipid-lowering combination therapy in very high-risk patients: not a choice, a necessity

Remnant cholesterol as a residual risk in ASCVD patients under statin-based lipid-lowering therapy

Association between remnant cholesterol and sarcopenia: implications on muscle health

Targeting remnant cholesterol in the era of precision lipid management

Recent trends and clinical evidence for optimizing lipid management

Environmental pollution as a nontraditional risk factor for atherosclerotic cardiovascular disease: mechanisms and impacts

Health inequity as a nontraditional risk factor for ASCVD

Psychiatric disorders: an overlooked nontraditional risk factor in the development of atherosclerotic cardiovascular disease

Biological and hormonal mechanisms linking sex and cardiometabolic risk

Sex and gender differences in risk assessment and biomarkers for cardiovascular disease

Do women and men respond differently to cardiometabolic therapies?

Safety and efficacy of moderate-intensity statin with ezetimibe in elderly patient with ASCVD

Strategies for managing hyperlipidemia in fragile elderly patients

Optimizing glucose control in fragile elderly patients with cardiometabolic syndrome

How to deal with multimorbidity and frailty for the prevention of cardiovascular disease

Reversing atherosclerosis - 20 years of data for CRESTOR

Atherosclerosis and lipid management in cancer survivors: balancing cardiovascular and oncologic risks

Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk equivalent

Atherosclerosis in chronic inflammatory diseases: focus on rheumatoid arthritis and systemic autoimmunity

IKKε-deficient macrophages impede cardiac repair after myocardial infarction by enhancing the macrophage-myofibroblast transition

Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis

Targeting the USP35–FASN axis and choline metabolism in cancer: a lipidomics perspective